Published on

Cost of ADHD Medication Adderall May Skyrocket

According to pharmaceutical industry reports, ADHD drug-maker Shire plans to raise the cost of Adderall 20 percent in coming months.

by ADDitude Editors

Adderall XR is nearing the end of its patent. Which means that, soon enough, generic versions of the widely popular ADHD medication will legally flood the market and bring down the cost of treating attention deficit disorder for millions of people. Or will it?

In anticipation of lost profits, drug-maker Shire is now reportedly increasing the price of Adderall by 20 percent in order to encourage consumers to try the relatively cheaper alternative medication Vyvanse. Once they're taking Vyvanse and seeing good results, the logic goes, consumers will be less likely to switch back to a cheaper Adderall generic when that becomes available.

Already, this strategy is earning Shire some benefits -- rumor has it that pharmaceutical giant Pfizer is looking to acquire the smaller U.K. drug maker.

Read more about the increasing price of Adderall...

Copyright © 1998 - 2013 New Hope Media LLC. All rights reserved. Your use of this site is governed by our
Terms of Service ( and
Privacy Policy (
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only.
See additional information at
New Hope Media, 39 W. 37th Street, 15th Floor, New York, NY 10018

Adult ADHD | Parenting ADHD Children | ADHD Treatment | School & Learning Disabilities | About ADHD | ADHD Resources | ADHD Community
Source: Cost of ADHD Medication Adderall May Skyrocket